サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1760887

医療微生物検査技術の世界市場

Medical Microbiology Testing Technologies

出版日
ページ情報
英文 173 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円
医療微生物検査技術の世界市場
出版日: 2025年07月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 173 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医療微生物検査技術の世界市場は2030年までに37億米ドルに到達

2024年に29億米ドルと推定される医療微生物検査技術の世界市場は、2024～2030年の分析期間においてCAGR 4.1%で成長し、2030年には37億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである呼吸器疾患は、CAGR 4.9%を記録し、分析期間終了時には14億米ドルに達すると予測されます。神経疾患分野の成長率は、分析期間中CAGR 3.6%と推定されます。

米国市場は7億4,710万米ドルと推定、中国はCAGR 7.1％で成長予測

米国の医療微生物検査技術市場は、2024年に7億4,710万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを7.1%として、2030年までに8億6,470万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.3%と3.1%と予測されています。欧州では、ドイツがCAGR 2.1%で成長すると予測されています。

世界の医療微生物検査技術市場- 主要動向と促進要因のまとめ

なぜ医療微生物検査技術はヘルスケアに不可欠なのか？

医療微生物検査技術は、感染因子を特定し、治療を決定し、疾病の発生を予防するために極めて重要です。これらの技術は、細菌、ウイルス、真菌感染の診断に使用され、呼吸器感染から院内感染に至るまで、さまざまな症状の管理に不可欠です。抗生物質耐性や新興感染症に対する懸念が高まる中、迅速で正確な微生物検査はヘルスケアにおける最優先事項となっています。医療用微生物検査は、疾病感染を減らし、公衆衛生イニシアチブをサポートする上で基本的な役割を果たしています。

どのような革新が医療微生物検査を推進しているのか？

分子診断学、ポリメラーゼ連鎖反応（PCR）技術、自動化された検査プラットフォームにおける技術の進歩は、医療微生物学に革命をもたらしました。分子診断学は遺伝子レベルでの病原体の迅速な検出を可能にし、従来の培養法と比較して数時間以内に結果を提供します。リアルタイムPCRのようなPCRの進歩は、検査の感度と精度を高め、より早期の診断と的を絞った治療を可能にします。自動化された検査プラットフォームとラボオンチップ技術は、検査プロセスを合理化し、迅速な納期と検査量の増加を可能にしました。これらの技術革新により、微生物学検査はより迅速かつ高精度になり、ヘルスケア施設全体で利用しやすくなりました。

微生物検査技術の利用をリードしている医療分野は？

高度な微生物検査に対する需要が最も高いのは、病院の検査室、公衆衛生局、外来診療所です。病院の検査室では、感染症の診断、抗生物質の使用指導、感染管理のために微生物検査を利用しています。公衆衛生機関は、感染症の発生を追跡し、公衆衛生対応に不可欠なデータを提供するために、これらの技術を使用しています。外来診療所では、一般的な感染症の迅速診断ツールの恩恵を受けており、迅速な治療が可能となっています。このようにヘルスケアの現場で広く採用されていることは、公衆衛生と患者の安全を維持する上で微生物学検査が果たす重要な役割を浮き彫りにしています。

医療微生物検査技術市場の成長はいくつかの要因によってもたらされる

医療微生物検査技術市場の成長は、感染症流行の増加、分子診断学の進歩、抗生物質耐性に対する意識の高まりなど、いくつかの要因によって牽引されています。感染症の世界の増加により、迅速で正確な検査ソリューションへの需要が高まっています。特にPCRと自動化における技術の進歩は、診断精度とスピードを向上させ、これらの技術をヘルスケアプロバイダーに不可欠なものにしています。さらに、抗生物質耐性に対抗することを目的とした公衆衛生イニシアチブは、微生物検査の重要性を強調し、市場の成長を促進し、高度な診断技術の採用を支援しています。

セグメント

用途（診断、治療モニタリング）;最終用途（病院ラボ、病理ラボ、研究機関）;適応症（呼吸器疾患、神経疾患、感染症）

調査対象企業の例（注目の41社）

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Himedia Laboratories
  • Hologic, Inc.
  • Thermo Fisher Scientific, Inc.

AI統合

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP16569

Global Medical Microbiology Testing Technologies Market to Reach US$3.7 Billion by 2030

The global market for Medical Microbiology Testing Technologies estimated at US$2.9 Billion in the year 2024, is expected to reach US$3.7 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Respiratory Diseases, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Neurological Diseases segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$747.1 Million While China is Forecast to Grow at 7.1% CAGR

The Medical Microbiology Testing Technologies market in the U.S. is estimated at US$747.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$864.7 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Medical Microbiology Testing Technologies Market - Key Trends & Drivers Summarized

Why Are Medical Microbiology Testing Technologies Vital in Healthcare?

Medical microbiology testing technologies are crucial for identifying infectious agents, guiding treatment decisions, and preventing disease outbreaks. These technologies are used to diagnose bacterial, viral, and fungal infections, essential for managing conditions ranging from respiratory infections to hospital-acquired infections. With rising concerns over antibiotic resistance and emerging infectious diseases, rapid and accurate microbiology testing has become a top priority in healthcare. Medical microbiology testing plays a fundamental role in reducing disease transmission and supporting public health initiatives.

What Innovations Are Driving Medical Microbiology Testing?

Technological advancements in molecular diagnostics, polymerase chain reaction (PCR) technology, and automated testing platforms have revolutionized medical microbiology. Molecular diagnostics enable rapid detection of pathogens at a genetic level, providing results within hours compared to traditional culture methods. PCR advancements, such as real-time PCR, enhance test sensitivity and accuracy, allowing for earlier diagnosis and targeted treatment. Automated testing platforms and lab-on-a-chip technologies have streamlined testing processes, enabling faster turnaround times and higher testing volumes. These innovations have made microbiology testing faster, more precise, and accessible across healthcare facilities.

Which Medical Sectors Are Leading the Use of Microbiology Testing Technologies?

The demand for advanced microbiology testing is highest in hospital laboratories, public health departments, and outpatient clinics. Hospital laboratories rely on microbiology testing for diagnosing infections, guiding antibiotic use, and managing infection control. Public health agencies use these technologies to track infectious disease outbreaks, providing essential data for public health responses. Outpatient clinics benefit from rapid diagnostic tools for common infections, allowing for prompt treatment. This widespread adoption across healthcare settings highlights the critical role of microbiology testing in maintaining public health and patient safety.

The Growth in the Medical Microbiology Testing Technologies Market Is Driven by Several Factors

The growth in the medical microbiology testing technologies market is driven by several factors, including the rise in infectious disease prevalence, advancements in molecular diagnostics, and increasing awareness of antibiotic resistance. The global increase in infectious diseases has heightened demand for fast, accurate testing solutions. Technological advancements, especially in PCR and automation, have enhanced diagnostic accuracy and speed, making these technologies indispensable for healthcare providers. Furthermore, public health initiatives aimed at combating antibiotic resistance have underscored the importance of microbiology testing, driving market growth and supporting the adoption of advanced diagnostic technologies.

SCOPE OF STUDY:

The report analyzes the Medical Microbiology Testing Technologies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Diagnostic, Treatment Monitoring); End-Use (Hospital Labs, Pathology Labs, Research Institutes); Indication (Respiratory Diseases, Neurological Diseases, Infectious Diseases)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Himedia Laboratories
  • Hologic, Inc.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Medical Microbiology Testing Technologies - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rapid Advances in Molecular Diagnostic Technologies for Faster and More Accurate Pathogen Detection
    • Growing Demand for Point-of-Care Microbiology Testing to Improve Turnaround Time in Clinical Settings
    • Expansion of Automated High-Throughput Microbiology Testing Platforms to Enhance Laboratory Efficiency
    • Increasing Preference for Real-Time PCR and Other Rapid Diagnostic Tests for Early Infection Control
    • Rising Focus on Pathogen-Specific Detection Technologies to Address Antimicrobial Resistance Challenges
    • Adoption of Lab-on-a-Chip and Biosensor Technologies for Portable and Cost-Effective Microbial Diagnostics
    • Growing Integration of Artificial Intelligence in Microbiology Testing for Predictive Analytics and Risk Assessment
    • Rising Demand for Microbiome Analysis in Personalized Treatment Plans for Infection-Related Disorders
    • Expansion of Home-Based and Remote Microbiology Testing Solutions to Broaden Access to Diagnostics
    • Increasing Use of Biomarker and Genomic Sequencing-Based Diagnostics for Precision Pathogen Detection
    • Growth in Public Health Initiatives to Expand Microbial Testing for Surveillance and Outbreak Control
    • Rising Investment in High-Sensitivity and Multiplex Microbiology Testing for Comprehensive Diagnostics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Medical Microbiology Testing Technologies Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Medical Microbiology Testing Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Medical Microbiology Testing Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Respiratory Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Respiratory Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Respiratory Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Neurological Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Neurological Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Neurological Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Treatment Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Treatment Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Treatment Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospital Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospital Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospital Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Pathology Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Pathology Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Pathology Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • JAPAN
    • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • CHINA
    • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • EUROPE
    • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Medical Microbiology Testing Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Medical Microbiology Testing Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • FRANCE
    • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • GERMANY
    • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • INDIA
    • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Medical Microbiology Testing Technologies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Medical Microbiology Testing Technologies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030
  • AFRICA
    • Medical Microbiology Testing Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Medical Microbiology Testing Technologies by Indication - Respiratory Diseases, Neurological Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Medical Microbiology Testing Technologies by Indication - Percentage Breakdown of Value Sales for Respiratory Diseases, Neurological Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Medical Microbiology Testing Technologies by Application - Diagnostic and Treatment Monitoring Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Medical Microbiology Testing Technologies by Application - Percentage Breakdown of Value Sales for Diagnostic and Treatment Monitoring for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Medical Microbiology Testing Technologies by End-Use - Hospital Labs, Pathology Labs and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Medical Microbiology Testing Technologies by End-Use - Percentage Breakdown of Value Sales for Hospital Labs, Pathology Labs and Research Institutes for the Years 2015, 2025 & 2030

IV. COMPETITION